ARTICLE

Volume 10,Issue 4

Cite this article
1
Download
3
Citations
12
Views
20 December 2025

Trends in Hospitalization Costs for COPD Patients: A Policy Coordination Perspective

Xuege Qiao1 Yin Wang1 Jiajia Zhao1 Xiaoyan Wang2 Zhong Lv1*
Show Less
1 Dongyang Hospital Affiliated to Wenzhou Medical University, Zhejiang 322100, China
2 Dongyang People’s Hospital, Zhejiang 322100, China
APM 2025 , 10(4), 234–240; https://doi.org/10.18063/APM.v10i4.1053
© 2025 by the Author. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Objective: To investigate the impact of integrating clinical pathways with Diagnosis-Related Groups (DRG) from a policy synergy perspective on hospitalization costs, healthcare efficiency, and cost structure for patients with chronic obstructive pulmonary disease (COPD), and to explore pathway optimization strategies adapting to the DRG 2.0 grouping policy, thereby enhancing the efficiency of medical insurance fund utilization. Methods: Using a tertiary hospital in Jinhua City as a case study, 7,015 medical insurance patients with a primary diagnosis of COPD admitted between 2020 and 2024 were selected. Interrupted Time Series Analysis (ITSA) and Structural Variation Analysis were employed to assess trends in hospitalization costs and other indicators. Results: Total hospitalization costs exhibited a significant short-term decrease (p = 0.003). Laboratory and examination costs decreased both in the short and long term (all p < 0.05). However, antimicrobial medication costs demonstrated a long-term upward trend (p = 0.007). Length of stay (LOS) decreased by 0.29 days in the short term. Western medications (contribution rate: 29.19%) and comprehensive medical services (contribution rate: 24.98%) were identified as key factors driving structural changes. Conclusion: Effective synergy between DRG and clinical pathways can reduce total hospitalization costs and shorten LOS for COPD patients, while optimizing cost structures. However, close attention must be paid to the unreasonable increase in antimicrobial medication costs. “Value-based healthcare” may represent a future trend for achieving a win-win scenario for cost control and healthcare quality.

Keywords
Clinical pathway
DRG 2.0
Chronic obstructive pulmonary disease (COPD)
Value-based healthcare
Funding
Zhejiang Kangenbei Hospital Management Soft Science Research Project (Project No.: 2025ZHA-KEB106)
References

[1] Mu M, 2023, Notice of the General Office of the National Healthcare Security Administration on Issuing the Version 2.0 Grouping Scheme for Diagnosis-Intervention Packet and Diagnosis-Specific Group Payment and on Further Promoting the Implementation of Relevant Work.

[2] He Z, Weng Y, Xia J, et al., 2022, Analysis of Implementation Elements and Strategies for Clinical Pathways Based on Grounded Theory. Chinese Hospital Management, 42(6): 56–60.

[3] Jie C, 2023, An Empirical Study on the Relationship Between Clinical Pathways and DRG in Public Hospitals, thesis, Anhui Medical University.

[4] Guo B, Gan H, Xue M, et al., 2024, The Changing and Predicted Trends in Chronic Obstructive Pulmonary Disease Burden in China, the United States, and India from 1990 to 2030. International Journal of Chronic Obstructive Pulmonary Disease, 19: 695–706.

[5] Gu C, Shi P, He M, et al., 2022, Study on the Implementation Effect of Clinical Pathway Under DRG Payment System: An Analysis Based on Interrupted Time Series Model. China Health Insurance, 2022(5): 11–16.

[6] Wu Y, Jia H, Zhu J, 2014, Study on Influencing Factors of Hospitalization Costs for Colorectal Cancer. Journal of Frontiers of Medicine, 2014(10): 135–136.

[7] Ma Z, Liu M, Hu J, et al., 2022, Impact of DRG Payment Reform on Per-Case Hospitalization Cost for Coronary Heart Disease Patients Based on New Grey Correlation and Structural Variation Degree. Chinese Hospital Management, 42(8): 70–73.

[8] Cao K, Cai S, Chen W, 2022, Integration and Optimization of DRG and Clinical Pathway Management Based on BP Artificial Neural Network Model. Hospital Management Forum, 39(4): 15–17 + 14.

[9] Zhang J, 2021, Analysis of the Impact of DRGs on Hospital Operation Management. China Management Informatization, 24(13): 56–57.

[10] Wu X, Zhuang Y, Dong S, et al., 2019, Strategy and Practice of Localized Improvement in Clinical Pathway Management. Chinese Hospital Management, 39(10): 34–35.

[11] Kong Z, Kong J, 2024, Reflections on Compliance in Public Hospitals Based on the Value-Instrument Framework. Chinese Journal of Hospital Administration, 40(10): 741–745.

[12] Chen H, Xia X, Zhou H, et al., 2022, Influencing Factors and Strategic Analysis of High-Quality Development in Public Hospitals. Chinese Journal of Hospital Administration, 38(8): 555–560.

Share
Back to top